ACS chemical neuroscience

zhurnal nevrologii i psikhiatrii imeni ss korsakova

BMC medical informatics and decision making

toxicology letters

Cells

frontiers in aging neuroscience

Biomolecules

journal of neurosurgery

Complementary therapies in medicine

brain and language

gait & posture

advances in experimental medicine and biology

Brain

Frontiers in neuroscience

BMC nursing

molecular neurobiology

frontiers in molecular neuroscience

journal of movement disorders

bmc neurology

acta neuropsychiatrica

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

The Journal of nervous and mental disease

Neural regeneration research

The International journal of neuroscience

interdisciplinary sciences, computational life sciences

journal of parkinson's disease

Journal of neural transmission (Vienna, Austria : 1996)

eurointervention : journal of europcr in collaboration with the working group on interventional cardiology of the european society of cardiology

american journal of stem cells

journal of critical care medicine (universitatea de medicina si farmacie din targu-mures)

ieee journal of translational engineering in health and medicine

Clinical parkinsonism & related disorders

[1] A Fully Automatic Framework for Parkinson's Disease Diagnosis by Multi-Modality Images.

[2] Nucleus basalis of Meynert neuronal activity in Parkinson's disease.

[3] Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis.

[4] Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease.

[5] Tai Chi and Parkinson's disease (PD): A systematic overview of the scientific quality of the past systematic reviews.

[6] Impact of motor fluctuations on real-life gait in Parkinson's patients.

[7] Altered Global Synchronizations in Patients With Parkinson's Disease: A Resting-State fMRI Study.

[8] Communication impairment in Parkinson's disease: Impact of motor and cognitive symptoms on speech and language.

[9] Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results.

[10] COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson's disease.

[11] A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy.

[12] Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.

[13] Accidental Modopar Poisoning in a Two-Year-Old Child: A Case Report.

[14] Impact of orthostatic hypotension on wheelchair use in patients with Parkinson's disease.

[15] [Subjective and objective subtypes of excessive daytime sleepiness in Parkinson's disease].

[16] Glial cells in intracerebral transplantation for Parkinson's disease.

[17] Perceived effects of Tango Argentino on body experience in persons with Parkinson's disease (PD)-A qualitative study with affected persons and their partners.

[18] Comparison of Spontaneous Motor Tempo during Finger Tapping, Toe Tapping and Stepping on the Spot in People with and without Parkinson's Disease.

[19] Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease.

[20] A Network Pharmacology-Based Study of the Molecular Mechanisms of Shaoyao-Gancao Decoction in Treating Parkinson's Disease.

[21] Automated Detection of Parkinson's Disease Based on Multiple Types of Sustained Phonations Using Linear Discriminant Analysis and Genetically Optimized Neural Network.

[22] Wearable Inertial Sensors to Assess Standing Balance: A Systematic Review

[23] How to Select Balance Measures Sensitive to Parkinson’s Disease from Body-Worn Inertial Sensors—Separating the Trees from the Forest

[24] Validity of a Fully-Immersive VR-Based Version of the Box and Blocks Test for Upper Limb Function Assessment in Parkinson’s Disease

[25] The Impact of a Novel Immersive Virtual Reality Technology Associated with Serious Games in Parkinson’s Disease Patients on Upper Limb Rehabilitation: A Mixed Methods Intervention Study

[26] Validity of a Fully-Immersive VR-Based Version of the Box and Blocks Test for Upper Limb Function Assessment in Parkinson’s Disease

[27] Reduced Gray Matter Volume and Risk of Falls in Parkinson’s Disease with Dementia Patients: A Voxel-Based Morphometry Study

[28] The Impact of a Novel Immersive Virtual Reality Technology Associated with Serious Games in Parkinson’s Disease Patients on Upper Limb Rehabilitation: A Mixed Methods Intervention Study

[29] Accurate fall detection for patients with Parkinson's disease based on a data event algorithm and wireless sensor nodes

[30] therapeutic potential of a prolyl hydroxylase inhibitor fg-4592 for parkinson’s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function

[31] evaluation of rna blood biomarkers in the parkinson’s disease biomarkers program

[32] serial dopamine transporter imaging of nigrostriatal function in parkinson’s disease with probable rem sleep behavior disorder

[33] gene therapy for the treatment of parkinson’s disease: the nature of the biologics expands the future indications

[34] dopaminergic progenitors derived from epiblast stem cells function similarly to primary vm-derived progenitors when transplanted into a parkinson’s disease model

[35] the enzymatic core of the parkinson’s disease-associated protein lrrk2 impairs mitochondrial biogenesis in aging yeast

[36] identification of circulating micrornas for the differential diagnosis of parkinson’s disease and multiple system atrophy.

[37] molecular diagnostics of neurodegenerative disorders

[38] phase-dependent modulation as a novel approach for therapeutic brain stimulation

[39] dj-1 inhibits α-synuclein aggregation by regulating chaperone-mediated autophagy

[40] protein phosphorylation in neurodegeneration: friend or foe?

[41] gait and tremor assessment for patients with parkinson’s disease using wearable sensors

[42] complementary & alternative management of parkinson’s disease: an evidence-based review of eastern influenced practices

[43] abnormal temporal coupling of tactile perception and motor action in parkinson’s disease

[44] eye movement control during visual pursuit in parkinson’s disease

[45] disrupted nodal and hub organization account for brain network abnormalities in parkinson’s disease

[46] p300 wave confirmation in patients with parkinson’s disease

[47] caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in parkinson’s disease

[48] Αlpha-synuclein as a mediator in the interplay between aging and parkinson’s disease

[49] a patient with recurrent dyskinesia and hyperpyrexia syndrome

[50] brain-derived neurotrophic factor serum levels correlate with cognitive performance in parkinson’s disease patients with mild cognitive impairment

[51] expression analysis of the long non-coding rna antisense to uchl1 (as uchl1) during dopaminergic cells’ differentiation in vitro and in neurochemical models of parkinson’s disease

[52] gender differences in age-related striatal dopamine depletion in parkinson’s disease

[53] antiparkinsonian efficacy of guanosine in rodent models of movement disorder

[54] glucocerebrosidase mutations and synucleinopathies. potential role of sterylglucosides and relevance of studying both gba1 and gba2 genes

[55] executive dysfunction in parkinson's disease and timing deficits

[56] parkinson’s disease severity at 3 years can be predicted from non-motor symptoms at baseline

[57] need for registration and reporting of acupuncture trials in parkinson’s disease in korea

[58] alterations of brain structural network in parkinson’s disease with and without rapid eye movement sleep behavior disorder

[59] neurochemical systems of the retina involved in the control of movement

[60] genetic factors and manganese-induced neurotoxicity

[61] Преимущества организации длительной когнитивной реабилитации при болезни Паркинсона в специализированном клинико-диагностическом кабинете

[62] neural foundations of action-related language: studies in parkinson’s disease

[63] effect of dopaminergic medication on postural sway in advanced parkinson’s disease

[64] rescue procedures after suboptimal deep brain stimulation outcomes in common movement disorders

[65] compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?

[66] modulation of alpha-synuclein expression and associated effects by microrna let-7 in transgenic c. elegans

[67] self-management in long term conditions using smartphones: a pilot study in parkinson’s disease

[68] the influences of age on olfaction: a review

[69] what is narrative bioethics

[70] cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early parkinson’s disease

[71] effects of rhythmic stimulus presentation on oscillatory brain activity: the physiology of cueing in parkinson’s disease

[72] long-term monitoring gait analysis using a wearable device in daily lives of patients with parkinson’s disease: the efficacy of selegiline hydrochloride for gait disturbance

[73] depression reduces accuracy while parkinsonism slows response time for processing positive feedback in patients with parkinson’s disease with comorbid major depressive disorder tested on a probabilistic category-learning task

[74] effects of sensitive electrical stimulation based cueing in parkinson's disease: a preliminary study

[75] akinetic crisis in parkinson's disease is associated with a severe loss of striatal dopamine transporter function: a report of two cases

[76] α-synuclein alters toll-like receptor expression

[77] ninetieth anniversary of parkinson’s disease «substantia nigra» theory

[78] investigating emotions in parkinson's disease: what we know and what we still don't know

[79] asthenia in patients with chronic neurological diseases

[80] Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation.

[81] Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency

[82] Intelligent Sensory Pen for Aiding in the Diagnosis of Parkinson’s Disease from Dynamic Handwriting Analysis

[83] Apigenin alleviates neuroinflammation in a mouse model of Parkinson's disease.

[84] Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [F]DPA-714 Targeting TSPO.

[85] Optic Tract Involvement in a Patient With Relapsing Polychondritis.

[86] Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson's Disease.

[87] Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.

[88] GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review

[89] The Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) Is a Valid and Low-Cost Tool for Evaluation of Dysphagia: A Gold-Standard Comparison Study

[90] Changes of Retina Are Not Involved in the Genesis of Visual Hallucinations in Parkinson’s Disease

[91] Biomechanical System Versus Observational Rating Scale for Parkinson’s Disease Tremor Assessment

[92] Quality of life in Parkinson’s disease patients: progression markers of mild to moderate stages

[93] Translational methods to detect asymmetries in temporal and spatial walking metrics in parkinsonian mouse models and human subjects with Parkinson’s disease

[94] Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease

[95] Effectiveness of SaeboReJoyce in the Evaluation of the Improvement of the Occupational Performance in Parkinson’s Disease: An Outcome Research

[96] Psychological Benefits of Nonpharmacological Methods Aimed for Improving Balance in Parkinson’s Disease: A Systematic Review

[97] Changes in Phonation and Their Relations with Progress of Parkinson’s Disease

[98] Centenary of Tretiakoff’s thesis on the morphology of Parkinson’s disease, evolved on the grounds of encephalitis lethargica pathology

[99] Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson’s disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation

[100] Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson’s disease using ¹⁸F-FDG PET imaging

[101] Classification of Patients with Parkinson’s Disease Using Medical Imaging and Artificial Intelligence Algorithms